Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingyun formula is a traditional Chinese medicine (TCM) herbal prescription. It is being studied in clinical settings, notably for the management of metabolic dysfunction-associated fatty liver disease (MAFLD). The specific composition and mechanism of action are not detailed in the available sources, but as a TCM formulation, it likely consists of multiple herbs designed to address disease through principles such as balancing Qi and improving organ function according to TCM theory. Its use in combination with digital management interventions suggests an integrative approach targeting both physiological and lifestyle factors[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingyun formula.